Skip to main content
SpringerLink
Log in

Clinical Features of Oxaliplatin-induced Hypersensitivity Reactions in Chinese Patients: A Retrospective Multicenter Analysis

  • Published:
Current Medical Science Aims and scope Submit manuscript

Abstract

Objective

The characteristics of oxaliplatin-induced hypersensitivity reactions (HSRs) in Chinese patients were investigated to provide a reference for patients treated with oxaliplatin.

Methods

The study reviewed the records of patients who developed oxaliplatin-induced HSRs in 17 hospitals from May 2016 to May 2017. We collected and analyzed the basic information, history of oxaliplatin administration and premedication treatments, chemotherapy cycles, HSR symptoms, and the management and outcomes of these patients.

Results

Oxaliplatin-induced HSRs were recorded in 137 patients who had been treated with oxaliplatin-containing regimens. Five different chemotherapy regimens were applied. The median infusion cycle when oxaliplatin-induced HSRs occurred was 7, and HSRs occurred during or shortly after oxaliplatin infusion. Most of the patients experienced grade 1 or grade 2 HSRs with mild symptoms of pruritis (49.64%), flushing (46.72%), chest discomfort (26.28%), and urticaria (25.55%). The majority of the patients completely recovered from HSRs following treatment with antihistamines and dexamethasone. Seven patients completed chemotherapy with oxaliplatin after the symptoms resolved with proper management.

Conclusion

The results indicate that oxaliplatin-induced HSRs remain an important issue in safely and successfully fulfilling oxaliplatin-containing chemotherapy. Further studies are needed to analyze the risk factors and establish prophylaxis for such reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ohta H, Hayashi T, Murai S, et al. Comparison between hypersensitivity reactionstocyclesofmodifiedFOLFOX6 and XELOX therapies in patients with colorectal cancer. Cancer Chemother Pharmacol, 2017,79(5):1021–1029

    Article  CAS  Google Scholar 

  2. Lee SY, Kang HR, Song WJ, et al. Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure. Cancer Chemother Pharmacol, 2014,73(2014):1021–1029

    Article  CAS  Google Scholar 

  3. Yamauchi H, Goto T, Takayoshi K, et al. A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin. Eur J Cancer Care, 2015,24(1):111–116

    Article  CAS  Google Scholar 

  4. Maindrault-Goebel F, André T, Tournigand C, et al. Allergic-type reactions to oxaliplatin: Retrospective analysis of 42 patients. Eur J Cancer, 2005,41(15):2262–2267

    Article  CAS  Google Scholar 

  5. Park SJ, Lee KY, Park WS, et al. Clinical Outcomes of Reintroducing Oxaliplatin to Patients with Colorectal Cancer after Mild Hypersensitivity Reactions. Oncology, 2013,85(6):323–327

    Article  CAS  Google Scholar 

  6. Parel M, Ranchon F, Nosbaum A, et al. Hypersensitivity to oxaliplatin: clinical features and risk factors. BMC Pharmacol Toxicol, 2014,15:1

    Article  Google Scholar 

  7. Aroldi F, Prochilo T, Bertocchi P, et al. Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management. J Chemother, 2015,27(2):63–66

    Article  CAS  Google Scholar 

  8. Kolomeyevskaya NV, Lele SB, Miller A, et al. Oxaliplatin Is a Safe Alternative Option for Patients with Recurrent Gynecologic Cancers After Hypersensitivity Reaction to Carboplatin. Int J Gynecol Cancer, 2015,25(1):42–48

    Article  Google Scholar 

  9. Kitada N, Dan T, Takara K, et al. CASE REPORT Oxaliplatin-induced hypersensitivity reaction displaying marked elevation of immunoglobulin E. J Oncol Pharm Practice, 2007,13(2007):233–235

    Article  CAS  Google Scholar 

  10. Kobayashi T, Masaki T, Kogawa K, et al. Hemoptysis and Acute Respiratory Syndrome (ARDS) as Delayed-Type Hypersensitivity After FOLFOX4 Plus Bevacizumab Treatment. Int Surg, 2013,98(2013):445–449

    Article  Google Scholar 

  11. Bautista MA, Bautista MA, Stevens WT, et al. Hypersensitivity reaction and acute immune mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. J Hematol Oncol, 2010, 12(3):1–8

    Google Scholar 

  12. Bano N, Najam R, Qazi F, et al. Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches. Asian Pac J Cancer Prev, 2016, 17(4):1637–1641

    Article  Google Scholar 

  13. Saif MW. Hypersensitivity reactions associated with oxaliplatin. Expert Opion Drug Saf, 2006,5(5):687–694

    Article  CAS  Google Scholar 

  14. Kim BH, Bradley T, Tai J, et al. Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review. Oncology, 2009,76:231–238

    Article  CAS  Google Scholar 

  15. Lenza G, Hackera UT, Kern W, et al. Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution. Anti-Cancer Drugs, 2003,14(2013):731–733

    Article  Google Scholar 

  16. Polyzos A, Tsavaris N, Gogas H, et al. Clinical Features of Hypersensitivity Reactions to Oxaliplatin: A 10-Year Experience. Oncology, 2008,76(1):36–41

    Article  Google Scholar 

  17. Makrilia N, Syrigou E, Kaklamanos I, et al. Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. Met Based Drugs, 2010,2010:207084

    Article  Google Scholar 

  18. Nozawa H, Muto Y, Yamada Y. Desensitization to Oxaliplatin with Two Stages of Premedication in a Patient with Metastatic Rectal Cancer. Clin Therap, 2008,30(6):1160–1165

    Article  CAS  Google Scholar 

  19. Toki MI, Saif MW, Syrigos KN. Hypersensitivity reactions associated with oxaliplatin and their clinical management. Expert Opion Drug Saf, 2014,13(11):1545–1554

    Article  CAS  Google Scholar 

  20. Gammon D, Bhargava P, Mccormick MJ. Hypersensitivity Reactions to Oxaliplatin and the Application of a Desensitization Protocol. Oncologist, 2004,9:546–549

    Article  CAS  Google Scholar 

  21. Syrigou EI, Karapanagiotou EM, Alamara CV, et al. Hypersensitivity Reactions to Oxaliplatin: A Retrospective Study and the Development of a Desensitization Protocol. Clin Colorectal Cancer, 2009, 8(2):106–109

    Article  CAS  Google Scholar 

  22. Siu SWK, Chan RTT, Au GKH. Hypersensitivity reactions to oxaliplatin: experience in a single institute. Ann Oncol, 2006,17:259–261

    Article  CAS  Google Scholar 

  23. Waddle M, Irvin M, Gupta E, et al. Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion. Chemotherapy, 2017,62(5):295–300

    Article  CAS  Google Scholar 

  24. Lai J, Wang W. Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review. Pharm World Sci, 2009,31(5):538–541

    Article  Google Scholar 

  25. Garciaz S, Oziel-Taieb S, Dermeche S, et al. Acute immune hematological complication of oxaliplatin. A series of 3 cases. Tumori, 2014,100(1):e17–e19

    Article  Google Scholar 

  26. Phull P, Quillen K, Hartshorn KL. Acute Oxaliplatin-induced Hemolytic Anemia, Thrombocytopenia, and Renal Failure: Case Report and a Literature Review. Clin Colorectal Cancer, 2017,16(2):e105–e107

    Article  Google Scholar 

  27. González-Mahave I, Lobera Iabairu T, Blasco Sarramián A, et al. Anaphylaxis produced by oxaliplatin. J Investig Allergol Clin immunol, 2005,15(1):75

    PubMed  Google Scholar 

  28. Shao Y, Hong R. Fatal Thrombocytopenia after Oxaliplatin-based Chemotherapy. Anticancer Res, 2008, 28(2008):3115–3118

    CAS  PubMed  Google Scholar 

  29. Kidera Y, Satoh T, Ueda S, et al. High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin. Int J Clin Oncol, 2011,16(2011):244–249

    Article  CAS  Google Scholar 

  30. Pagani M, Bonadonna P. Skin Test Protocol for the Prevention of Hypersensitivity Reactions to Oxaliplatin. Anticancer Res, 2014,34(2014):537–540

    CAS  PubMed  Google Scholar 

  31. Garufi C, Cristaudo A, Vanni B, et al. Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol, 2003,14:497–498

    Article  CAS  Google Scholar 

  32. Zhang X, Zhao Y, Zheng Y, et al. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions. J Investig Allergol Clin Immunol, 2017,27(1):65–66

    Article  Google Scholar 

  33. Yanai T, Iwasa S, Hashimoto H, et al. Successful Rechallenge for Oxaliplatin Hypersensitivity Reactions in Patients with Metastatic Colorectal Cancer. Anticancer Res, 2012,32:5521–5526

    CAS  PubMed  Google Scholar 

  34. Rose PG, Metz C, Link N. Desensitization With Oxaliplatin in Patients Intolerant of Carboplatin Desensitization. Int J Gynecoll Cancer, 2014,24(9):1603–1606

    Article  Google Scholar 

  35. Edmondson DA, Gruling BJ, Urmanski AM, et al. Oxaliplatin Hypersensitivity: Case Report and Successful Repeat Desensitization. Am J Therapeut, 2007,14(2007):116–118

    Article  Google Scholar 

  36. Wong JT, Ling M, Patil S, et al. Oxaliplatin Hypersensitivity: Evaluation, Implications of Skin Testing, and Desensitization. J Allergy Clin Immunol Pract, 2013,2(1):40–45

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Min Li, Chen Jiang, Jing-wen Yang, Zao-qin Yu, Wei Li, Cheng-liang Zhang & Dong Liu

  2. Hubei Center for Adverse Drug Reaction Monitoring, Wuhan, 430030, China

    Li Zhao

  3. People’s Hospital of Yuxi City, Yuxi, 653100, China

    Qiu-yan Song

Authors
  1. Min Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing-wen Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zao-qin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qiu-yan Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Cheng-liang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Cheng-liang Zhang or Dong Liu.

Ethics declarations

There is no conflict of interest in the submitted work.

Additional information

This work was supported by grants from the Hubei Center for Adverse Drug Reaction Monitoring (No. 20160422), and the Research-oriented Clinician Plan of Tongji Medical College, Huazhong University of Science and Technology (No. 5001540076).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, M., Jiang, C., Yang, Jw. et al. Clinical Features of Oxaliplatin-induced Hypersensitivity Reactions in Chinese Patients: A Retrospective Multicenter Analysis. CURR MED SCI 41, 827–831 (2021). https://doi.org/10.1007/s11596-021-2387-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-021-2387-1

Key words

Search

Navigation